|
|
|
| home > ict > Winter 2009 |
|
|
 PUBLICATIONS |
International Clinical Trials |
|
|
|
|
| At the cutting edge of the latest industry developments, Samedan is adept at keeping the information you need at your fingertips. ICT provides a unique platform of communication for the market across Europe, North America and the rest of the developed world. To find out what's hot in the world of pharmaceuticals, take a look below at the range of articles featured in this issue of ICT |
 |
| |
|
|
|
|
| As clinical trial locations go global, the level of risk grows proportionally. James Walters of Aon Risk Services presents strategies to ensure the successful launch of a trial. |
|
|
| John Wilkinson of Reed Smith examines the regulations in the UK surrounding human embryonic stem cell therapies. |
|
|
|
| With the decline in development productivity, Alistair Sinclair of Datamonitor discusses how technical collaborations can optimise R&D strategies. |
|
|
| Xunting Zeng at InCROM explains how the revision of Chinese regulations has necessitated a streamlined system that aims to encourage innovation. |
|
|
| South and Central America is attracting attention as an evermore important area for clinical research. Gabriela Rácaro at PAREXEL International analyses the evolution that has taken place over the last decade. |
|
|
|
Companies are turning to 'smart' technologies in order to improve productivity. Ed Seguine of Medidata Solutions believes that eProtocol will rejuvenate the industry. |
|
|
|
| Robyn Roper at Wolters Kluwer Health argues that improving the process of collating, validating and interpreting clinical data will increase trial transparency. |
|
|
| Internet connectivity levels in Africa are extremely low, making it difficult to implement EDC in clinical trials - yet thinking outside the box and utilising different technologies may be the answer, points out Richard Young at Cmed. |
|
|
| Dacid Stein of Perceptive Informatics calls on eClinical integration improvements – a vital step if biopharmaceutical companies are to succeed in their competitive marketplace. |
|
|
| Ed Krasovec of STARLIMS Corporation sets out guidelines on implementing a unified informatics platform in order to manage laboratory operations in accordance with protocol and regulatory requirements |
|
|
| Maintaining volunteers' safety remains of paramount importance in clinical trials. Philippe L'Hostis of Biotrial examines the advantages of using digital ECGs during studies. |
|
|
|
| Fred Pritchard at MDS Pharma Services describes the challenges facing studies of Alzheimer's disease and the steps that can be taken to overcome them. |
|
|
| Spirometric data must be precise in order to ensure it is of the highest quality. Aleck Harrison at AJH Partners outlines the four main variables that can affect the results. |
|
|
|
|
| Translating trial questionnaires is a complex and delicate process. Simon Andriesen at MediLingua highlights the guidelines that currently exist and some of the key issues to consider. |
|
|
| With an increasing number of products demanding cold chain shipment, a close partnering between sponsors, contractors and technology specialists is required, explain John Engelhardt and Keren Winmill at Penn Pharma. |
|
|
| Jonathan Calderwood of Almac Group examines the fundamental components of an efficient and cost-effective cold chain process. |
|
|
|
|
|
 |
|
|
 |
News and Press Releases |
 |
Digital Health and Wearables
• Datwyler uses strategic partnerships to develop new solutions in the fields of wearables and digital health.
• The company’s health care offering is always designed towards improving the comfort of patients during treatment.
• The product portfolio and innovative healthcare solutions will be presented at several important trade fairs of the medical sector.
More info >> |
|
 |
White Papers |
 |
|
eSource: Reducing Site Workload for Better, Faster, Safer Clinical Trials
Clinical Ink
Unlike traditional electronic data capture (EDC),
SureSource, Clinical Ink’s eSource platform, was designed from the
beginning to minimize clinical trial complexity for site users. A Site Impact Survey provides
scientific evidence regarding the impact of SureSource from 517 site
users. Results confirm it significantly reduces workload, lessens
queries, and improves data quality compared to paper and EDC. In this
white paper, we quantitatively evaluate survey outcomes, provide
qualitative feedback from survey respondents, and highlight the observed
benefits of SureSource for transforming clinical research.
More info >> |
|
 |
Industry Events |
 |
CPhI & P-MEC India 2018
12-14 December 2018, India Expo Mart, New Delhi, India
CPhI & P-MEC India (December 12-14, 2018) – organised by UBM (part
of Informa PLC) – announces that the 12th edition of Asia’s
largest Pharma exhibition is moving to the India Expo Mart, New Delhi. The new
venue will see the exhibition now hosted in a single venue, bringing it closer
to the Indian regulatory and legislative capital. New Delhi is also the
country’s main international transport hub and will encourage an increased
international attendance. In total, more than 50,000 people from 122 countries
are expected, along with nearly 1,500 exhibitors.
More info >> |
|
|
